Yahoo Web Search

Search results

  1. The SEER database tracks 5-year relative survival rates for osteosarcoma in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by MSTS or TNM stages (stage 1, stage 2, stage 3, etc.).

  2. May 23, 2023 · Death rates for osteosarcoma have steadily declined by approximately 1.3% per year. The 5-year overall survival rate is about 68%, regardless of sex. Osteosarcoma accounts for approximately 2.4% of pediatric cancers, making it the eighth most common childhood malignancy.

    • Stephanie Prater, Brett McKeon
    • 2023/05/23
    • Aventura Hospital & Medical Center
  3. For all registered patients at a median follow-up of 54 months (interquartile range: 38–73) from biopsy, 3-year and 5-year event-free survival were 59% (95% confidence interval [CI]: 57–61%) and 54% (95% CI: 52–56%), respectively.

    • Sigbjørn Smeland, Stefan S. Bielack, Jeremy Whelan, Mark Bernstein, Pancras Hogendoorn, Mark D. Krai...
    • 10.1016/j.ejca.2018.11.027
    • 2019
    • Eur J Cancer. 2019 Mar; 109: 36-50.
  4. According to the American Cancer Society, the current five-year relative survival rates for osteosarcoma are: 76% if the tumor is localized with no sign of cancer spread beyond the bone where it originated. 64% if the tumor has spread outside the bone and into nearby lymph nodes or other tissues.

  5. Feb 28, 2022 · Incidence and survival rates for 5016 patients with osteosarcoma from the Surveillance, Epidemiology, and End Results (SEER) program (1975-2017) were analyzed by age (0-9, 10-24, 25-59, and >60 years old), race/ethnicity, histologic subtype, stage, and tumor location using SEER*Stat software.

    • 26
    • 128, Issue11
    • 28 February 2022
  6. Nov 24, 2021 · After 10 to 12 weeks of standard neoadjuvant therapy, about 55% of patients have a good response, with a 5-year survival rate of about 75%.

  7. People also ask

  8. Dec 8, 2022 · The age-adjusted incidence rate was 1.9 per million for those aged 0–9 years, 6.7 per million for those aged 10–24 years, 1.9 per million for those aged 25–59 years and 2 per million for ...